Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Lennox-Gastaut syndrome

- PMLiVE

UCB CEO: Patient info more important than transparency

Roch Doliveux says misinformation is the “worst thing that can happen in healthcare”

- PMLiVE

UCB says new medicines drive growth in 2012

Also optimistic about its late-stage pipeline

- PMLiVE

UCB signs research deal for novel neuroscience drugs

Partners with structural biology company ConfometRx

- PMLiVE

UCB-Amgen pull development of drug to heal fractures

But romosozumab remains on course in postmenopausal osteoporosis

- PMLiVE

Will opportunity knock for eHealth in 2013?

If EC plans succeed, they will transform the way technology is used

UCB launches arthritis exercise programme in the UK

Scheme was piloted at two NHS Trusts during 2011

- PMLiVE

Eliquis and Ryzodeg feature among Japan’s year-end approvals

Actonel and Neupro also given green light

- PMLiVE

New EC anti-smoking plans include ban on flavoured tobacco

Pictorial health warnings on cigarettes and regulation for e-cigarettes also proposed

- PMLiVE

EC appoints group to examine biotech patent laws

Will examine role of patents in genetic engineering

- PMLiVE

UCB strikes new Middle East and African sales deal for key products

Drops the RX Group to partner with NewBridge Pharmaceuticals

Eisai: Bucking the trend with R&D growth

PME’s emerging companies series continues with a firm that’s committed to research as it expands its commercial position

EU flag

Europe launches health plan for its ageing population

Improved adherence and greater use of telehealth named as key areas

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links